KRAS and neoplasm: We compared the clinical variables according to the presence of recurrence, and no differences were observed in all factors, including tumor location, histology, lymphovascular invasion, perineural invasion, KRAS mutation, MSI status, T stage, N stage, and laboratory findings (Table 2).